Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
76
-
Total shares
-
9.81M
-
Shares change
-
-493K
-
Total reported value, excl. options
-
$305M
-
Value change
-
-$14.5M
-
Number of buys
-
37
-
Number of sells
-
-28
-
Price
-
$31.08
Significant Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q2 2019
75 filings reported holding EIDX - EIDOS THERAPEUTICS INC - COM as of Q2 2019.
EIDOS THERAPEUTICS INC - COM (EIDX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.81M shares
.
Largest 10 shareholders include BlackRock Inc. (1.37M shares), Aisling Capital Management LP (1.12M shares), Viking Global Investors LP (882K shares), Redmile Group, LLC (878K shares), PERCEPTIVE ADVISORS LLC (687K shares), LORD, ABBETT & CO. LLC (574K shares), Cormorant Asset Management, LP (552K shares), VANGUARD GROUP INC (376K shares), Candriam Luxembourg S.C.A. (323K shares), and Opaleye Management Inc. (306K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.